You are here: Industry Insights > API

News List

Pharmaceutical product shortage and imbalance between supply and demand of global APIs Xiaoyaowan
May 20, 2020
Globally, the R&D of therapeutic drugs and prophylactic vaccines still needs time, and each country can only rely on the prevention and control method of early diagnosis and early isolation.
CDSCO issues recommendations to lift export restrictions on paracetamol APIs expresspharma
May 18, 2020
The letter states that six major manufacturers may be allowed to export up to 50 per cent of their monthly operating capacity in a given month subject to release of a similar quantity for domestic purpose.
Hikal announces development of Favipiravir APIs and its intermediates expresspharma
May 15, 2020
The company is in discussion with potential partners to supply the API and its intermediates.
Quartic.ai Partners with Bright Path Labs contractpharma
May 07, 2020
Collaborate to develop AI-powered continuous manufacturing of critical APIs for medicines.
CDSCO to assess issues in the procurement and prices of APIs expresspharma
May 06, 2020
Reportedly, prices of APIs for paracetamol has increased exponentially from approximately Rs 250 per kg to Rs 425 per kg in the last three months.
NPPA allows six paracetamol APIS manufacturers to export 2000 MT expresspharma
May 04, 2020
Permissions have been granted to Farmson Pharmaceuticals, Meghmani LLP, Sri Krishna Pharmaceutical, Granules India, Bharat Chemicals and Para Products based on DoPs assessment of the availability of paracetamol APIs and KSMs.
Laurus Labs’ PAT touches Rs 110 crore in Q4 expresspharma
May 04, 2020
The consolidated revenue for the quarter was up by 32 per cent to Rs 839 crore as against Rs 635 crore in Q4 FY'19, a press release from the company said.
Wavelength Pharmaceuticals expands supplies of key drug ingredients for critically ill COVID-19 patients pharmaceutical-business-review
April 26, 2020
Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients (APIs), today reported that it has greatly expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients.
IICT, LAXAI LifeSciences collaborate for key pharma intermediates expresspharma
April 26, 2020
The collaboration will primarily focus on umifenovir, remdesivir and a key intermediate of hydroxychloroquine.
DCGI instructs SDCs to monitor supply and availability of paracetamol tablets, APIs expresspharma
April 24, 2020
Manufacturers of paracetamol tablets need to supply the minimum quantity but not less than their average supply of the past three months (January, February and March) in the domestic market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 21 22 Next page